|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3,830.00 KRW | +9.59% |
|
-6.81% | -44.33% |
| 04-13 | Genome & Company announced that it has received KRW 6.99999414 billion in funding | CI |
| 04-02 | Genome & Company announced that it expects to receive KRW 6.99999414 billion in funding | CI |
Quotes 5-day view: Genome & Company
End-of-day quote Korea S.E.| 03/07/2026 | 06/07/2026 | 07/07/2026 | 08/07/2026 | Today | |
|---|---|---|---|---|---|
| Last | ₩3,760.00 | ₩3,560.00 | ₩3,765.00 | ₩3,495.00 | ₩3,830.00 |
| Volume | 395,557 | 289,601 | 325,976 | 280,893 | 455,014 |
| Change | +1.21% | -5.32% | +5.76% | -7.17% | +9.59% |
| Opening | ₩3,825.00 | ₩3,780.00 | ₩3,500.00 | ₩3,720.00 | ₩3,435.00 |
| High | ₩3,840.00 | ₩3,855.00 | ₩3,930.00 | ₩3,765.00 | ₩3,940.00 |
| Low | ₩3,520.00 | ₩3,510.00 | ₩3,500.00 | ₩3,440.00 | ₩3,435.00 |
Performance
| 1 day | +9.59% | ||
| 1 week | -6.81% | ||
| Current month | -0.78% | ||
| 1 month | -20.95% | ||
| 3 months | -44.57% | ||
| 6 months | -47.25% | ||
| Current year | -44.33% | ||
| 1 year | +26.82% | ||
| 3 years | -50.64% | ||
| 5 years | -79.49% |
Volumes
marketsDaily volume
455,014
Avg. Volume 20 sessions
443,324
Avg. Volume 20 sessions KRW
1,697,930,920
Avg. Volume 20 sessions USD
1,127,426.13
Record volume 1
30,576,260
Record volume 2
14,495,024
Record volume 3
7,918,904
Capital turnover ratio
0.01
Float rotation
0.01
Basic data
Market Cap (KRW)
157,802,531,712
Market Cap (USD)
104,520,216
Net sales ()
24,586,847,080
Net sales (USD)
16,285,053
Free-Float
82.77 %
Free-Float capitalization (KRW)
130,612,180,149
Free-Float capitalization (USD)
86,510,737
Average Daily Capital Traded
1.08%
Indicators
Moving average 5 days
3,682
Moving average 20 days
4,361.75
Moving average 50 days
5,524.2
Moving average 100 days
6,508.2
Price spread / (MMA5)
-3.86%
Price spread / (MMA20)
+13.88%
Price spread / (MMA50)
+44.23%
Price spread / (MMA100)
+69.93%
RSI 9 days
41.9
RSI 14 days
39.59
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +9.59% | -6.81% | +26.82% | -50.64% | 105M | |
| +1.68% | +3.55% | +4.86% | +10.97% | 49.42B | |
| +0.72% | +1.00% | +396.18% | +602.43% | 40.34B | |
| +2.54% | +0.93% | +28.98% | -4.77% | 34.01B | |
| +0.31% | +1.74% | +18.44% | +57.29% | 33.56B | |
| -2.09% | -0.80% | +3.56% | +33.56% | 26.84B | |
| -0.63% | +0.34% | - | - | 17.22B | |
| +0.66% | -3.96% | +66.85% | +121.47% | 15.19B | |
| -23.90% | -21.43% | +50.06% | +53.83% | 13.96B | |
| +2.59% | +0.50% | +15.28% | +21.25% | 13.36B | |
| Average | -0.86% | +0.93% | +67.89% | +93.93% | 24.4B | |
| Weighted average by Cap. | -0.62% | +0.90% | +87.50% | +133.97% |
Historical Quotes: Genome & Company
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Course Extremes
| 1 week | 3,435 |  | 3,940 |
| 1 month | 3,435 | | 6,130 |
| Current year | 3,435 | | 10,180 |
| 1 year | 2,440 | | 10,180 |
| 3 years | 2,170 | | 10,180 |
| 5 years | 2,170 | | 28,800 |
| 10 years | 2,170 | | 47,500 |
Monthly variations
Annual variations
| 2026 | -44.33% | ||
| 2025 | +150.18% | ||
| 2024 | -55.96% | ||
| 2023 | -28.42% | ||
| 2022 | -49.71% | ||
| 2021 | -56.35% | ||
| 2020 | +102.29% | ||
| 2019 | +219.51% | ||
| 2018 | +31.83% |
- Stock Market
- Stocks
- A314130 Stock
- Quotes Genome & Company
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
